Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 25 entries
Sorted by: Best Match Show Resources per page
Human herpesvirus-8 (HHV-8) sero-detection and HIV association in Kaposi's sarcoma (KS), non-KS tumors and non-neoplastic conditions.

Infectious agents and cancer

Mwakigonja AR, Pyakurel P, Kokhaei P, Pak F, Lema LK, Kaaya EE, Biberfeld P.
PMID: 18590556
Infect Agent Cancer. 2008 Jun 30;3:10. doi: 10.1186/1750-9378-3-10.

BACKGROUND: The association of the human herpesvirus-8/Kaposi's sarcoma (KS)-associated herpesvirus (HHV-8/KSHV) serology with various malignancies in Tanzania is not currently well established while previous studies were based on either PCR or immunofluorescence assays [IFA] but not with a sensitive...

Cite
Mwakigonja AR, Pyakurel P, Kokhaei P, et al. Human herpesvirus-8 (HHV-8) sero-detection and HIV association in Kaposi's sarcoma (KS), non-KS tumors and non-neoplastic conditions. Infect Agent Cancer. 2008;3:10doi: 10.1186/1750-9378-3-10.
Mwakigonja, A. R., Pyakurel, P., Kokhaei, P., Pak, F., Lema, L. K., Kaaya, E. E., & Biberfeld, P. (2008). Human herpesvirus-8 (HHV-8) sero-detection and HIV association in Kaposi's sarcoma (KS), non-KS tumors and non-neoplastic conditions. Infectious agents and cancer, 310. https://doi.org/10.1186/1750-9378-3-10
Mwakigonja, Amos R, et al. "Human herpesvirus-8 (HHV-8) sero-detection and HIV association in Kaposi's sarcoma (KS), non-KS tumors and non-neoplastic conditions." Infectious agents and cancer vol. 3 (2008): 10. doi: https://doi.org/10.1186/1750-9378-3-10
Mwakigonja AR, Pyakurel P, Kokhaei P, Pak F, Lema LK, Kaaya EE, Biberfeld P. Human herpesvirus-8 (HHV-8) sero-detection and HIV association in Kaposi's sarcoma (KS), non-KS tumors and non-neoplastic conditions. Infect Agent Cancer. 2008 Jun 30;3:10. doi: 10.1186/1750-9378-3-10. PMID: 18590556; PMCID: PMC2499990.
Copy Download .nbib Format: NLM
Oncogenesis in HIV-infection.

International journal of oncology

Albini A, Aluigi M, Benelli R, Berti E, Biberfeld P, Blasig C, Calabro M, Calvo F, Chiecobianchi L, Corbellino M, Delmistro A, Ekman M, Favero A, Hofschneider P, Kaaya E, Lebbe C, Morel P, Neipel F, Noonan D, Parravicini C, Repetto L, Schalling M, Sturzl M, Tschachler E.
PMID: 21541473
Int J Oncol. 1996 Jul;9(1):5-8.

The presence of human Kaposi's sarcoma associated herpesvirus-like sequences (KSHV) was examined in different epidemiological variants of Kaposi's sarcoma (KS) and in KS-derived cell cultures by polymerase chain reaction (PCR). KSHV DNA was present in all tumor biopsies of...

Cite
Albini A, Aluigi M, Benelli R, et al. Oncogenesis in HIV-infection. Int J Oncol. 1996;9(1):5-8
Albini, A., Aluigi, M., Benelli, R., Berti, E., Biberfeld, P., Blasig, C., Calabro, M., Calvo, F., Chiecobianchi, L., Corbellino, M., Delmistro, A., Ekman, M., Favero, A., Hofschneider, P., Kaaya, E., Lebbe, C., Morel, P., Neipel, F., Noonan, D., Parravicini, C., Repetto, L., Schalling, M., Sturzl, M., & Tschachler, E. (1996). Oncogenesis in HIV-infection. International journal of oncology, 9(1), 5-8.
Albini, A, et al. "Oncogenesis in HIV-infection." International journal of oncology vol. 9,1 (1996): 5-8.
Albini A, Aluigi M, Benelli R, Berti E, Biberfeld P, Blasig C, Calabro M, Calvo F, Chiecobianchi L, Corbellino M, Delmistro A, Ekman M, Favero A, Hofschneider P, Kaaya E, Lebbe C, Morel P, Neipel F, Noonan D, Parravicini C, Repetto L, Schalling M, Sturzl M, Tschachler E. Oncogenesis in HIV-infection. Int J Oncol. 1996 Jul;9(1):5-8. PMID: 21541473.
Copy Download .nbib Format: NLM
Frequent Anti-V1V2 Responses Induced by HIV-DNA Followed by HIV-MVA with or without CN54rgp140/GLA-AF in Healthy African Volunteers.

Microorganisms

Msafiri F, Joachim A, Held K, Nadai Y, Chissumba RM, Geldmacher C, Aboud S, Stöhr W, Viegas E, Kroidl A, Bakari M, Munseri PJ, Wahren B, Sandström E, Robb ML, McCormack S, Joseph S, Jani I, Ferrari G, Rao M, Biberfeld G, Lyamuya E, Nilsson C.
PMID: 33158007
Microorganisms. 2020 Nov 04;8(11). doi: 10.3390/microorganisms8111722.

Antibody responses that correlated with reduced risk of HIV acquisition in the RV144 efficacy trial were assessed in healthy African volunteers who had been primed three times with HIV-DNA (subtype A, B, C) and then randomized into two groups;...

Cite
Msafiri F, Joachim A, Held K, et al. Frequent Anti-V1V2 Responses Induced by HIV-DNA Followed by HIV-MVA with or without CN54rgp140/GLA-AF in Healthy African Volunteers. Microorganisms. 2020;8(11)doi: 10.3390/microorganisms8111722.
Msafiri, F., Joachim, A., Held, K., Nadai, Y., Chissumba, R. M., Geldmacher, C., Aboud, S., Stöhr, W., Viegas, E., Kroidl, A., Bakari, M., Munseri, P. J., Wahren, B., Sandström, E., Robb, M. L., McCormack, S., Joseph, S., Jani, I., Ferrari, G., Rao, M., Biberfeld, G., Lyamuya, E., & Nilsson, C. (2020). Frequent Anti-V1V2 Responses Induced by HIV-DNA Followed by HIV-MVA with or without CN54rgp140/GLA-AF in Healthy African Volunteers. Microorganisms, 8(11), . https://doi.org/10.3390/microorganisms8111722
Msafiri, Frank, et al. "Frequent Anti-V1V2 Responses Induced by HIV-DNA Followed by HIV-MVA with or without CN54rgp140/GLA-AF in Healthy African Volunteers." Microorganisms vol. 8,11 (2020). doi: https://doi.org/10.3390/microorganisms8111722
Msafiri F, Joachim A, Held K, Nadai Y, Chissumba RM, Geldmacher C, Aboud S, Stöhr W, Viegas E, Kroidl A, Bakari M, Munseri PJ, Wahren B, Sandström E, Robb ML, McCormack S, Joseph S, Jani I, Ferrari G, Rao M, Biberfeld G, Lyamuya E, Nilsson C. Frequent Anti-V1V2 Responses Induced by HIV-DNA Followed by HIV-MVA with or without CN54rgp140/GLA-AF in Healthy African Volunteers. Microorganisms. 2020 Nov 04;8(11). doi: 10.3390/microorganisms8111722. PMID: 33158007; PMCID: PMC7693996.
Copy Download .nbib Format: NLM
King Charles VIII of France's Death: From an Unsubstantiated Traumatic Brain Injury to More Realistic Hypotheses.

World neurosurgery

Zanello M, Roux A, Gavaret M, Bartolomei F, Huberfeld G, Charlier P, Georges-Zimmermann P, Carron R, Pallud J.
PMID: 34537407
World Neurosurg. 2021 Dec;156:60-67. doi: 10.1016/j.wneu.2021.09.056. Epub 2021 Sep 17.

On April 7, 1498, Charles VIII, King of France, attended a game of palm in the ditches of the Château d'Amboise. The 27-year-old King suddenly collapsed and became comatose. He laid down, almost on his own, on a straw...

Cite
Zanello M, Roux A, Gavaret M, et al. King Charles VIII of France's Death: From an Unsubstantiated Traumatic Brain Injury to More Realistic Hypotheses. World Neurosurg. 2021;156:60-67doi: 10.1016/j.wneu.2021.09.056.
Zanello, M., Roux, A., Gavaret, M., Bartolomei, F., Huberfeld, G., Charlier, P., Georges-Zimmermann, P., Carron, R., & Pallud, J. (2021). King Charles VIII of France's Death: From an Unsubstantiated Traumatic Brain Injury to More Realistic Hypotheses. World neurosurgery, 15660-67. https://doi.org/10.1016/j.wneu.2021.09.056
Zanello, Marc, et al. "King Charles VIII of France's Death: From an Unsubstantiated Traumatic Brain Injury to More Realistic Hypotheses." World neurosurgery vol. 156 (2021): 60-67. doi: https://doi.org/10.1016/j.wneu.2021.09.056
Zanello M, Roux A, Gavaret M, Bartolomei F, Huberfeld G, Charlier P, Georges-Zimmermann P, Carron R, Pallud J. King Charles VIII of France's Death: From an Unsubstantiated Traumatic Brain Injury to More Realistic Hypotheses. World Neurosurg. 2021 Dec;156:60-67. doi: 10.1016/j.wneu.2021.09.056. Epub 2021 Sep 17. PMID: 34537407.
Copy Download .nbib Format: NLM
AIDS-associated kaposis-sarcoma in tanzanians of Indian origin - report of cases and review of literature.

International journal of oncology

Kaaya E, Amir H, Kitinya J, Luande J, Ordonez C, Biberfeld P.
PMID: 21566978
Int J Oncol. 1994 Mar;4(3):689-93. doi: 10.3892/ijo.4.3.689.

Kaposi's sarcoma (KS) was up to the 1980's seen as a rare indolent sporadic disease in Southern Europe and as an endemic disease in East and Central Africa. With the onset of the HIV/AIDS epidemic a more aggressive, disseminated...

Cite
Kaaya E, Amir H, Kitinya J, et al. AIDS-associated kaposis-sarcoma in tanzanians of Indian origin - report of cases and review of literature. Int J Oncol. 1994;4(3):689-93doi: 10.3892/ijo.4.3.689.
Kaaya, E., Amir, H., Kitinya, J., Luande, J., Ordonez, C., & Biberfeld, P. (1994). AIDS-associated kaposis-sarcoma in tanzanians of Indian origin - report of cases and review of literature. International journal of oncology, 4(3), 689-93. https://doi.org/10.3892/ijo.4.3.689
Kaaya, E, et al. "AIDS-associated kaposis-sarcoma in tanzanians of Indian origin - report of cases and review of literature." International journal of oncology vol. 4,3 (1994): 689-93. doi: https://doi.org/10.3892/ijo.4.3.689
Kaaya E, Amir H, Kitinya J, Luande J, Ordonez C, Biberfeld P. AIDS-associated kaposis-sarcoma in tanzanians of Indian origin - report of cases and review of literature. Int J Oncol. 1994 Mar;4(3):689-93. doi: 10.3892/ijo.4.3.689. PMID: 21566978.
Copy Download .nbib Format: NLM
Kaposi sarcoma-associated herpesvirus/human herpesvirus 8, cytokines, growth factors and HIV in pathogenesis of Kaposi's sarcoma.

Current opinion in infectious diseases

Biberfeld P, Ensoli B, Stürzl M, Schulz TF.
PMID: 17033372
Curr Opin Infect Dis. 1998 Apr;11(2):97-105. doi: 10.1097/00001432-199804000-00002.

Epidemiological studies have strengthened the case for Kaposi sarcoma-associated herpesvirus/human herpesvirus 8 being the long-sought Kaposi sarcoma agent, but have also pointed to a role for other co-factors. Like other tumour viruses, Kaposi sarcoma-associated herpesvirus/human herpesvirus 8 establishes a...

Cite
Biberfeld P, Ensoli B, Stürzl M, et al. Kaposi sarcoma-associated herpesvirus/human herpesvirus 8, cytokines, growth factors and HIV in pathogenesis of Kaposi's sarcoma. Curr Opin Infect Dis. 1998;11(2):97-105doi: 10.1097/00001432-199804000-00002.
Biberfeld, P., Ensoli, B., Stürzl, M., & Schulz, T. F. (1998). Kaposi sarcoma-associated herpesvirus/human herpesvirus 8, cytokines, growth factors and HIV in pathogenesis of Kaposi's sarcoma. Current opinion in infectious diseases, 11(2), 97-105. https://doi.org/10.1097/00001432-199804000-00002
Biberfeld, P, et al. "Kaposi sarcoma-associated herpesvirus/human herpesvirus 8, cytokines, growth factors and HIV in pathogenesis of Kaposi's sarcoma." Current opinion in infectious diseases vol. 11,2 (1998): 97-105. doi: https://doi.org/10.1097/00001432-199804000-00002
Biberfeld P, Ensoli B, Stürzl M, Schulz TF. Kaposi sarcoma-associated herpesvirus/human herpesvirus 8, cytokines, growth factors and HIV in pathogenesis of Kaposi's sarcoma. Curr Opin Infect Dis. 1998 Apr;11(2):97-105. doi: 10.1097/00001432-199804000-00002. PMID: 17033372.
Copy Download .nbib Format: NLM
Evaluation of HIV-1/HIV-2 immunoblots for detection of HIV-2 antibodies.

Clinical and diagnostic virology

Walther L, Putkonen P, Dias F, Biberfeld G, Thorstensson R.
PMID: 15566829
Clin Diagn Virol. 1995 Jul;4(1):67-79. doi: 10.1016/0928-0197(94)00057-2.

OBJECTIVE: To evaluate the sensitivity of commercially available HIV-2 immunoblots and to identify the HIV-2 glycoproteins on Western blots.METHODS: HIV-2 Western blot (WB) strips commercially available from Diagnostic Biotechnology, Diagnostic Pasteur and Cambridge Biotech and in-house HIV-2 WB strips...

Cite
Walther L, Putkonen P, Dias F, et al. Evaluation of HIV-1/HIV-2 immunoblots for detection of HIV-2 antibodies. Clin Diagn Virol. 1995;4(1):67-79doi: 10.1016/0928-0197(94)00057-2.
Walther, L., Putkonen, P., Dias, F., Biberfeld, G., & Thorstensson, R. (1995). Evaluation of HIV-1/HIV-2 immunoblots for detection of HIV-2 antibodies. Clinical and diagnostic virology, 4(1), 67-79. https://doi.org/10.1016/0928-0197(94)00057-2
Walther, L, et al. "Evaluation of HIV-1/HIV-2 immunoblots for detection of HIV-2 antibodies." Clinical and diagnostic virology vol. 4,1 (1995): 67-79. doi: https://doi.org/10.1016/0928-0197(94)00057-2
Walther L, Putkonen P, Dias F, Biberfeld G, Thorstensson R. Evaluation of HIV-1/HIV-2 immunoblots for detection of HIV-2 antibodies. Clin Diagn Virol. 1995 Jul;4(1):67-79. doi: 10.1016/0928-0197(94)00057-2. PMID: 15566829.
Copy Download .nbib Format: NLM
EUROPAEM EMF Guideline 2015 for the prevention, diagnosis and treatment of EMF-related health problems and illnesses.

Reviews on environmental health

Belyaev I, Dean A, Eger H, Hubmann G, Jandrisovits R, Johansson O, Kern M, Kundi M, Lercher P, Mosgöller W, Moshammer H, Müller K, Oberfeld G, Ohnsorge P, Pelzmann P, Scheingraber C, Thill R.
PMID: 26613329
Rev Environ Health. 2015;30(4):337-71. doi: 10.1515/reveh-2015-0033.

Chronic diseases and illnesses associated with unspecific symptoms are on the rise. In addition to chronic stress in social and work environments, physical and chemical exposures at home, at work, and during leisure activities are causal or contributing environmental...

Cite
Belyaev I, Dean A, Eger H, et al. EUROPAEM EMF Guideline 2015 for the prevention, diagnosis and treatment of EMF-related health problems and illnesses. Rev Environ Health. 2015;30(4):337-71doi: 10.1515/reveh-2015-0033.
Belyaev, I., Dean, A., Eger, H., Hubmann, G., Jandrisovits, R., Johansson, O., Kern, M., Kundi, M., Lercher, P., Mosgöller, W., Moshammer, H., Müller, K., Oberfeld, G., Ohnsorge, P., Pelzmann, P., Scheingraber, C., & Thill, R. (2015). EUROPAEM EMF Guideline 2015 for the prevention, diagnosis and treatment of EMF-related health problems and illnesses. Reviews on environmental health, 30(4), 337-71. https://doi.org/10.1515/reveh-2015-0033
Belyaev, Igor, et al. "EUROPAEM EMF Guideline 2015 for the prevention, diagnosis and treatment of EMF-related health problems and illnesses." Reviews on environmental health vol. 30,4 (2015): 337-71. doi: https://doi.org/10.1515/reveh-2015-0033
Belyaev I, Dean A, Eger H, Hubmann G, Jandrisovits R, Johansson O, Kern M, Kundi M, Lercher P, Mosgöller W, Moshammer H, Müller K, Oberfeld G, Ohnsorge P, Pelzmann P, Scheingraber C, Thill R. EUROPAEM EMF Guideline 2015 for the prevention, diagnosis and treatment of EMF-related health problems and illnesses. Rev Environ Health. 2015;30(4):337-71. doi: 10.1515/reveh-2015-0033. PMID: 26613329.
Copy Download .nbib Format: NLM
Frequent and Durable Anti-HIV Envelope VIV2 IgG Responses Induced by HIV-1 DNA Priming and HIV-MVA Boosting in Healthy Tanzanian Volunteers.

Vaccines

Joachim A, Msafiri F, Onkar S, Munseri P, Aboud S, Lyamuya EF, Bakari M, Billings E, Robb ML, Wahren B, Mhalu FS, Sandström E, Rao M, Nilsson C, Biberfeld G.
PMID: 33202967
Vaccines (Basel). 2020 Nov 13;8(4). doi: 10.3390/vaccines8040681.

We evaluated antibody responses to the human immunodeficiency virus (HIV) envelope variable regions 1 and 2 (V1V2) in 29 vaccinees who had received three HIV-1 DNA immunizations and two HIV-modified vaccinia virus Ankara (MVA) boosts in the phase I/II...

Cite
Joachim A, Msafiri F, Onkar S, et al. Frequent and Durable Anti-HIV Envelope VIV2 IgG Responses Induced by HIV-1 DNA Priming and HIV-MVA Boosting in Healthy Tanzanian Volunteers. Vaccines (Basel). 2020;8(4)doi: 10.3390/vaccines8040681.
Joachim, A., Msafiri, F., Onkar, S., Munseri, P., Aboud, S., Lyamuya, E. F., Bakari, M., Billings, E., Robb, M. L., Wahren, B., Mhalu, F. S., Sandström, E., Rao, M., Nilsson, C., & Biberfeld, G. (2020). Frequent and Durable Anti-HIV Envelope VIV2 IgG Responses Induced by HIV-1 DNA Priming and HIV-MVA Boosting in Healthy Tanzanian Volunteers. Vaccines, 8(4), . https://doi.org/10.3390/vaccines8040681
Joachim, Agricola, et al. "Frequent and Durable Anti-HIV Envelope VIV2 IgG Responses Induced by HIV-1 DNA Priming and HIV-MVA Boosting in Healthy Tanzanian Volunteers." Vaccines vol. 8,4 (2020). doi: https://doi.org/10.3390/vaccines8040681
Joachim A, Msafiri F, Onkar S, Munseri P, Aboud S, Lyamuya EF, Bakari M, Billings E, Robb ML, Wahren B, Mhalu FS, Sandström E, Rao M, Nilsson C, Biberfeld G. Frequent and Durable Anti-HIV Envelope VIV2 IgG Responses Induced by HIV-1 DNA Priming and HIV-MVA Boosting in Healthy Tanzanian Volunteers. Vaccines (Basel). 2020 Nov 13;8(4). doi: 10.3390/vaccines8040681. PMID: 33202967; PMCID: PMC7711440.
Copy Download .nbib Format: NLM
Time to dispense with antiepileptic drug prophylaxis in brain tumor surgery?.

Neuro-Chirurgie

Pallud J, Huberfeld G.
PMID: 35039165
Neurochirurgie. 2021 Dec 31; doi: 10.1016/j.neuchi.2021.12.003. Epub 2021 Dec 31.

No abstract available.

Cite
Pallud J, Huberfeld G. Time to dispense with antiepileptic drug prophylaxis in brain tumor surgery?. Neurochirurgie. 2021;doi: 10.1016/j.neuchi.2021.12.003.
Pallud, J., & Huberfeld, G. (2021). Time to dispense with antiepileptic drug prophylaxis in brain tumor surgery?. Neuro-Chirurgie, . https://doi.org/10.1016/j.neuchi.2021.12.003
Pallud, J, and Huberfeld, G. "Time to dispense with antiepileptic drug prophylaxis in brain tumor surgery?." Neuro-Chirurgie vol. (2021). doi: https://doi.org/10.1016/j.neuchi.2021.12.003
Pallud J, Huberfeld G. Time to dispense with antiepileptic drug prophylaxis in brain tumor surgery?. Neurochirurgie. 2021 Dec 31; doi: 10.1016/j.neuchi.2021.12.003. Epub 2021 Dec 31. PMID: 35039165.
Copy Download .nbib Format: NLM
King Charles VIII of France's Death: From an Unsubstantiated Traumatic Brain Injury to More Realistic Hypotheses.

World neurosurgery

Zanello M, Roux A, Gavaret M, Bartolomei F, Huberfeld G, Charlier P, Georges-Zimmermann P, Carron R, Pallud J.
PMID: 34537407
World Neurosurg. 2021 Dec;156:60-67. doi: 10.1016/j.wneu.2021.09.056. Epub 2021 Sep 17.

On April 7, 1498, Charles VIII, King of France, attended a game of palm in the ditches of the Château d'Amboise. The 27-year-old King suddenly collapsed and became comatose. He laid down, almost on his own, on a straw...

Cite
Zanello M, Roux A, Gavaret M, et al. King Charles VIII of France's Death: From an Unsubstantiated Traumatic Brain Injury to More Realistic Hypotheses. World Neurosurg. 2021;156:60-67doi: 10.1016/j.wneu.2021.09.056.
Zanello, M., Roux, A., Gavaret, M., Bartolomei, F., Huberfeld, G., Charlier, P., Georges-Zimmermann, P., Carron, R., & Pallud, J. (2021). King Charles VIII of France's Death: From an Unsubstantiated Traumatic Brain Injury to More Realistic Hypotheses. World neurosurgery, 15660-67. https://doi.org/10.1016/j.wneu.2021.09.056
Zanello, Marc, et al. "King Charles VIII of France's Death: From an Unsubstantiated Traumatic Brain Injury to More Realistic Hypotheses." World neurosurgery vol. 156 (2021): 60-67. doi: https://doi.org/10.1016/j.wneu.2021.09.056
Zanello M, Roux A, Gavaret M, Bartolomei F, Huberfeld G, Charlier P, Georges-Zimmermann P, Carron R, Pallud J. King Charles VIII of France's Death: From an Unsubstantiated Traumatic Brain Injury to More Realistic Hypotheses. World Neurosurg. 2021 Dec;156:60-67. doi: 10.1016/j.wneu.2021.09.056. Epub 2021 Sep 17. PMID: 34537407.
Copy Download .nbib Format: NLM
Quantitative brain imaging analysis of neurological syndromes associated with anti-GAD antibodies.

NeuroImage. Clinical

Dade M, Giry M, Berzero G, Benazra M, Huberfeld G, Leclercq D, Navarro V, Delattre JY, Psimaras D, Alentorn A.
PMID: 34563986
Neuroimage Clin. 2021 Sep 20;32:102826. doi: 10.1016/j.nicl.2021.102826. Epub 2021 Sep 20.

Neurological disorders associated with anti-glutamic acid decarboxylase (GAD) autoimmunity are rare and include a variety of neurological syndromes: stiff-person syndrome, cerebellar ataxia or limbic encephalitis. The diagnosis remains challenging due to the variety of symptoms and normal brain imaging....

Cite
Dade M, Giry M, Berzero G, et al. Quantitative brain imaging analysis of neurological syndromes associated with anti-GAD antibodies. Neuroimage Clin. 2021;32:102826doi: 10.1016/j.nicl.2021.102826.
Dade, M., Giry, M., Berzero, G., Benazra, M., Huberfeld, G., Leclercq, D., Navarro, V., Delattre, J. Y., Psimaras, D., & Alentorn, A. (2021). Quantitative brain imaging analysis of neurological syndromes associated with anti-GAD antibodies. NeuroImage. Clinical, 32102826. https://doi.org/10.1016/j.nicl.2021.102826
Dade, Maëlle, et al. "Quantitative brain imaging analysis of neurological syndromes associated with anti-GAD antibodies." NeuroImage. Clinical vol. 32 (2021): 102826. doi: https://doi.org/10.1016/j.nicl.2021.102826
Dade M, Giry M, Berzero G, Benazra M, Huberfeld G, Leclercq D, Navarro V, Delattre JY, Psimaras D, Alentorn A. Quantitative brain imaging analysis of neurological syndromes associated with anti-GAD antibodies. Neuroimage Clin. 2021 Sep 20;32:102826. doi: 10.1016/j.nicl.2021.102826. Epub 2021 Sep 20. PMID: 34563986; PMCID: PMC8476448.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 25 entries